SARS-COVID-19 antibodies in pregnant women at a level III hospital in Peru

Título traducido de la contribución: Anticuerpos anti-SARS-CoV-2 en gestantes en un hospital nivel III de Perú

Enrique Guevara-Ríos, Marcos Espinola-Sánchez, César Carranza-Asmat, Félix Ayala-Peralta, Ricardo Álvarez-Carrasco, Antonio Luna-Figueroa, Luis Meza-Santibáñez, Carlos Pérez-Aliaga, Kelly Zevallos-Espinoza, Augusto Racchumi-Vela, Jorge Segundo-Paredes, Pedro Arango-Ochante

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

5 Citas (Scopus)

Resumen

Introduction: COVID-19 disease spreads rapidly. Seroprevalence in pregnant women entering for hospitalization and clinical characteristics in this type of population in Peru is not known. Objective: To determine the prevalence and clinical-epidemiological characteristics of pregnant women with anti-SARS-CoV-2 antibodies at a level III hospital in Peru. Methods: Observational and cross-sectional study performed at the National Maternal Perinatal Institute of Peru. Pregnant women admitted for hospitalization were screened for COVID-19 infection. Results of anti-SARSCoV-2 serological tests and information on maternal and perinatal characteristics were obtained. Data analysis was performed using descriptive statistics and 95% confidence intervals. Results: In 2 419 pregnant women screened we identified a prevalence of 7.0% of anti-SARS-CoV-2 antibodies (95% IC: 6.1% to 8.1%), including IgM in 10% (95% IC: 6.1% to 15.8%), IgM / IgG in 78.8% (95% IC: 71.8% to 84.6%), IgG in 11.2% (95% IC: 7.0% to 17.1%). 89.4% of the seropositive pregnant women were asymptomatic. Most frequent complications were premature rupture of membranes (11.8%) and preeclampsia (6.5%). No association was found between clinical and epidemiologic characteristics and type of serological response to SARS-CoV-2 (p > 0.05). Conclusions: Pregnant women had prevalence of anti-SARS-CoV-2 antibodies of 7.0% on admission to the hospital; most of them were asymptomatic. There was no association between clinical-epidemiological characteristics analyzed and type of anti-SARS-CoV-2 antibody response.

Título traducido de la contribuciónAnticuerpos anti-SARS-CoV-2 en gestantes en un hospital nivel III de Perú
Idioma originalInglés
Páginas (desde-hasta)19-25
Número de páginas7
PublicaciónRevista Peruana de Ginecologia y Obstetricia
Volumen66
N.º3
DOI
EstadoPublicada - 2020

Nota bibliográfica

Publisher Copyright:
© 2020 Revista Peruana de Ginecologia y Obstetricia. All rights reserved.

Huella

Profundice en los temas de investigación de 'Anticuerpos anti-SARS-CoV-2 en gestantes en un hospital nivel III de Perú'. En conjunto forman una huella única.

Citar esto